Skip navigation
  • Sciety Labs đŸ§Ș (Experimental)
  • Search
Sciety application utilities

Infectious Diseases (except HIV/AIDS)

  • Subscribe to feed (RSS)

Showing page 162 of 716 pages of list content

  • Post COVID-19 condition of the Omicron variant of SARS-CoV-2

    This article's authors
    1. Shinichiro Morioka
    2. Shinya Tsuzuki
    3. Michiyo Suzuki
    4. Mari Terada
    5. Masako Akashi
    6. Yasuyo Osanai
    7. Chika Kuge
    8. Mio Sanada
    9. Keiko Tanaka
    10. Taketomo Maruki
    11. Kozue Takahashi
    12. Sho Saito
    13. Kayoko Hayakawa
    14. Katsuji Teruya
    15. Masayuki Hojo
    16. Norio Ohmagari
    This article has 1 evaluations Latest evaluation on May 18, 2022 Published on May 16, 2022
  • Elevated liver enzymes and bilirubin following SARS-CoV-2 infection in children under 10

    This article's authors
    1. Ellen K. Kendall
    2. Veronica R. Olaker
    3. David C. Kaelber
    4. Rong Xu
    5. Pamela B. Davis
    This article has 3 evaluations Latest evaluation on Aug 2, 2022 Published on May 14, 2022
  • The preliminary safety and immunogenicity results of a randomized, double-blind, placebo-controlled Phase I trial for a recombinant two-component subunit SARS-CoV-2 vaccine ReCOV

    This article's authors
    1. Chris Wynne
    2. Paul Hamilton
    3. Jingxin Li
    4. Chen Mo
    5. Jiaping Yu
    6. Wenrong Yao
    7. Zijing Yue
    8. Xi Zhang
    9. Jianhui Zhang
    10. Kunxue Hong
    11. Jianping Chen
    12. Yong Liu
    13. Fengcai Zhu
    This article has 1 evaluations Latest evaluation on May 17, 2022 Published on May 14, 2022
  • Comparative study between first and second wave of COVID-19 deaths in India - a single center study

    This article's authors
    1. Prakash Tendulkar
    2. Pragya Pandey
    3. Prasan Kumar Panda
    4. Ajeet Singh Bhadoria
    5. Poorvi Kulshreshtha
    6. Mayank Mishra
    7. Gaurika Saxena
    This article has 1 evaluations Latest evaluation on May 14, 2022 Published on May 10, 2022
  • BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants

    This article's authors
    1. Annika Rössler
    2. Antonia Netzl
    3. Ludwig Knabl
    4. Helena SchÀfer
    5. Samuel H. Wilks
    6. David Bante
    7. Barbara Falkensammer
    8. Wegene Borena
    9. Dorothee von Laer
    10. Derek Smith
    11. Janine Kimpel
    This article has 1 evaluations Latest evaluation on May 14, 2022 Published on May 10, 2022
  • Influencing factors of Anti-SARS-CoV-2-Spike IgG antibody titres in healthcare workers – A cross-section study

    This article's authors
    1. Julia Reusch
    2. Isabell WagenhÀuser
    3. Alexander Gabel
    4. Annika Eggestein
    5. Anna Höhn
    6. ThiĂȘn-TrĂ­ LĂąm
    7. Anna Frey
    8. Alexandra Schubert-Unkmeir
    9. Lars Dölken
    10. Stefan Frantz
    11. Oliver Kurzai
    12. Ulrich Vogel
    13. Manuel Krone
    14. Nils Petri
    This article has 1 evaluations Latest evaluation on May 14, 2022 Published on May 10, 2022
  • High but Short-lived anti-SARS-CoV2 neutralizing, IgM, IgA, and IgG levels among mRNA-vaccinees compared to naturally-infected participants

    This article's authors
    1. Haissam Abou-Saleh
    2. Bushra Y. Abo-Halawa
    3. Salma Younes
    4. Nadin Younes
    5. Duaa W. Al-Sadeq
    6. Farah M. Shurrab
    7. Na Liu
    8. Hamda Qotba
    9. Nader Al-Dewik
    10. Ahmad H. Ismail
    11. Hadi M. Yassine
    12. Laith J. Abu-Raddad
    13. Gheyath K. Nasrallah
    This article has 1 evaluations Latest evaluation on May 14, 2022 Published on May 10, 2022
  • mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia

    This article's authors
    1. Rui Li
    2. Hanting Liu
    3. Christopher K Fairley
    4. Jason J Ong
    5. Yuming Guo
    6. Zhuoru Zou
    7. Li Xie
    8. Guihua Zhuang
    9. Yan Li
    10. Mingwang Shen
    11. Lei Zhang
    This article has 1 evaluations Latest evaluation on May 14, 2022 Published on May 10, 2022
  • 10.4 Million Children Affected by COVID-19-associated Orphanhood and Caregiver Death: An Imperative for Action

    This article's authors
    1. Susan Hillis
    2. Joel-Pascal Ntwali N’konzi
    3. William Msemburi
    4. Lucie Cluver
    5. Andrés Villaveces
    6. Seth Flaxman
    7. H. Juliette T. Unwin
    This article has 1 evaluations Latest evaluation on May 14, 2022 Published on May 10, 2022
  • Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B

    This article's authors
    1. Natalia Martin Orozco
    2. Noah Vale
    3. Alan Mihic
    4. Talya Amor
    5. Lawrence Reiter
    6. Yuko Arita
    7. Reuben Samson
    8. Queenie Hu
    9. Anne-Claude Gingras
    10. Brad Sorenson
    11. Eric G. Marcusson
    12. Piyush Patel
    This article has 1 evaluations Latest evaluation on May 14, 2022 Published on May 10, 2022
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information